Edesa Biotech EDSA
NASDAQ EDSA
$2.85 +0.03 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Edesa Biotech (EDSA) Work In Process (2015)

Updated

Edesa Biotech (EDSA) posted Work In Process of $137,021 for fiscal Q4 2015 (quarter ended Sep 30, 2015), up 69.7% from the prior quarter.

Analysis

Edesa Biotech (EDSA) Work In Process (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Edesa Biotech 26.08 Mn -19.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 137,021.00
Jun 30, 2015 80,720.00
API Access

Edesa Biotech Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=EDSA&period=max&api_key=YOUR_API_KEY